
A dozen people came down with mpox in Chicago around early May, prompting the Centers for Disease Control and Prevention to warn doctors of a potential mpox resurgence.
To those that were watching mpox closely, the increase in U.S. cases wasn't a surprise. New cases had been recently reported in Europe, and U.S. health officials had been warning that low mpox vaccination rates in many parts of the country left at-risk people particularly vulnerable.